1. Home
  2. LCUT vs IFRX Comparison

LCUT vs IFRX Comparison

Compare LCUT & IFRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lifetime Brands Inc.

LCUT

Lifetime Brands Inc.

HOLD

Current Price

$3.40

Market Cap

69.1M

ML Signal

HOLD

Logo InflaRx N.V.

IFRX

InflaRx N.V.

HOLD

Current Price

$0.88

Market Cap

60.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCUT
IFRX
Founded
1945
2007
Country
US
US
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
69.1M
60.6M
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
LCUT
IFRX
Price
$3.40
$0.88
Analyst Decision
Hold
Strong Buy
Analyst Count
2
6
Target Price
$4.75
$8.50
AVG Volume (30 Days)
19.0K
443.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
5.00%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$682,952,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.07
$1,054.36
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.89
$0.71
52 Week High
$5.78
$1.94

Technical Indicators

Market Signals
Indicator
LCUT
IFRX
Relative Strength Index (RSI) 42.04 42.41
Support Level $3.26 $0.81
Resistance Level $3.54 $0.90
Average True Range (ATR) 0.16 0.07
MACD 0.02 0.00
Stochastic Oscillator 57.14 26.28

Price Performance

Historical Comparison
LCUT
IFRX

About LCUT Lifetime Brands Inc.

Lifetime Brands Inc is a U.S. based company that designs, sources, and sells branded kitchenware, tableware, and other products used in the home and markets its products under brands such as Farberware, KitchenAid, Mikasa, and others. The company markets and sells its products principally on a wholesale basis to retailers. It also markets and sells a limited selection of its products directly to consumers through its Pfaltzgraff, Mikasa, Fred, and Friends, Built NY, and others. Its products include kitchen tools, gadgets, cutlery, dinnerware, and glassware. The segments of the company are the U.S. and International. It derives a majority of its revenue from the U.S. segment. The company derives maximum revenue from Kitchenware products.

About IFRX InflaRx N.V.

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

Share on Social Networks: